The Vanguard Group 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-10 12:15 pm Purchase |
2024-05-31 | 13G | United Therapeutics Corporation UTHR |
The Vanguard Group | 4,687,393 10.570% |
13,715 (+0.29%) |
Filing |
| 2024-02-13 5:15 pm Purchase |
2023-12-29 | 13G | United Therapeutics Corporation UTHR |
The Vanguard Group | 4,673,678 9.950% |
192,959 (+4.31%) |
Filing |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | United Therapeutics Corporation UTHR |
The Vanguard Group | 4,480,719 9.830% |
319,756 (+7.68%) |
Filing |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | United Therapeutics Corporation UTHR |
The Vanguard Group | 4,160,963 9.240% |
196,962 (+4.97%) |
Filing |
| 2021-02-10 11:57 am Sale |
2020-12-31 | 13G | United Therapeutics Corporation UTHR |
The Vanguard Group | 3,964,001 8.920% |
-88,046 (-2.17%) |
Filing |